AC Immune SA (ACIU) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
AC Immune SA (ACIU) Bundle
Explore the financial future of AC Immune SA (ACIU) with our user-friendly DCF Calculator! Enter your assumptions for growth, margins, and costs to calculate the intrinsic value of AC Immune SA (ACIU) and inform your investment decisions.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 123.3 | 17.1 | .0 | 4.4 | 16.4 | 12.9 | 10.1 | 7.9 | 6.2 | 4.9 |
Revenue Growth, % | 0 | -86.1 | -100 | 0 | 276.14 | -21.53 | -21.53 | -21.53 | -21.53 | -21.53 |
EBITDA | 49.5 | -68.1 | -85.7 | -76.7 | -57.6 | -4.1 | -3.2 | -2.5 | -2.0 | -1.6 |
EBITDA, % | 40.11 | -396.99 | 100 | -1754.87 | -350.19 | -31.98 | -31.98 | -31.98 | -31.98 | -31.98 |
Depreciation | 1.9 | 2.2 | 2.1 | 2.6 | 2.5 | 4.9 | 3.8 | 3.0 | 2.4 | 1.9 |
Depreciation, % | 1.53 | 12.75 | 100 | 59.95 | 14.97 | 37.84 | 37.84 | 37.84 | 37.84 | 37.84 |
EBIT | 47.6 | -70.2 | -87.8 | -79.3 | -60.0 | -4.2 | -3.3 | -2.6 | -2.0 | -1.6 |
EBIT, % | 38.59 | -409.74 | 100 | -1814.82 | -365.16 | -32.28 | -32.28 | -32.28 | -32.28 | -32.28 |
Total Cash | 320.6 | 251.0 | 220.2 | 136.2 | 114.5 | 12.9 | 10.1 | 7.9 | 6.2 | 4.9 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 1.2 | 1.8 | 1.1 | .9 | 16.7 | 6.0 | 4.7 | 3.7 | 2.9 | 2.3 |
Account Receivables, % | 0.98626 | 10.31 | 100 | 20.33 | 101.66 | 46.33 | 46.33 | 46.33 | 46.33 | 46.33 |
Inventories | -1.6 | -2.1 | -1.6 | .0 | .0 | 2.2 | 1.7 | 1.4 | 1.1 | .8 |
Inventories, % | -1.26 | -12.44 | 100 | 0.000025412961 | 0 | 17.26 | 17.26 | 17.26 | 17.26 | 17.26 |
Accounts Payable | .2 | 2.4 | 2.2 | 1.0 | 1.9 | 3.9 | 3.0 | 2.4 | 1.9 | 1.5 |
Accounts Payable, % | 0.1279 | 14.15 | 100 | 23.61 | 11.34 | 29.85 | 29.85 | 29.85 | 29.85 | 29.85 |
Capital Expenditure | -2.1 | -1.9 | -2.9 | -1.4 | -.9 | -1.3 | -1.0 | -.8 | -.6 | -.5 |
Capital Expenditure, % | -1.7 | -11.06 | 100 | -31.49 | -5.41 | -9.93 | -9.93 | -9.93 | -9.93 | -9.93 |
Tax Rate, % | -0.01844236 | -0.01844236 | -0.01844236 | -0.01844236 | -0.01844236 | -0.01844236 | -0.01844236 | -0.01844236 | -0.01844236 | -0.01844236 |
EBITAT | 47.6 | -70.5 | -87.8 | -79.4 | -60.1 | -4.2 | -3.3 | -2.6 | -2.0 | -1.6 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | 47.9 | -67.9 | -88.7 | -80.7 | -73.5 | 9.9 | .5 | .4 | .3 | .2 |
WACC, % | 10.39 | 10.39 | 10.39 | 10.39 | 10.39 | 10.39 | 10.39 | 10.39 | 10.39 | 10.39 |
PV UFCF | ||||||||||
SUM PV UFCF | 10.0 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 0 | |||||||||
Terminal Value | 3 | |||||||||
Present Terminal Value | 2 | |||||||||
Enterprise Value | 12 | |||||||||
Net Debt | -83 | |||||||||
Equity Value | 95 | |||||||||
Diluted Shares Outstanding, MM | 85 | |||||||||
Equity Value Per Share | 1.12 |
What You Will Get
- Real AC Immune Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for AC Immune SA (ACIU).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to AC Immune SA (ACIU).
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on AC Immune SA (ACIU)'s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for AC Immune SA (ACIU).
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility for AC Immune SA (ACIU).
Key Features
- Comprehensive Financial Data: Gain access to reliable pre-loaded historical figures and future forecasts for AC Immune SA (ACIU).
- Adjustable Projection Parameters: Modify highlighted cells for metrics like WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: Intuitive charts and summaries to help visualize your valuation outcomes.
- Suitable for All Levels: Designed for investors, CFOs, and consultants with a straightforward, easy-to-navigate layout.
How It Works
- Step 1: Download the prebuilt Excel template featuring AC Immune SA’s (ACIU) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalculated results, including AC Immune SA’s (ACIU) intrinsic value.
- Step 5: Use the outputs to make informed investment decisions or create detailed reports.
Why Choose This Calculator for AC Immune SA (ACIU)?
- Accuracy: Utilizes real AC Immune financials to ensure precise data.
- Flexibility: Tailored for users to easily test and adjust inputs as needed.
- Time-Saving: Avoid the complexities of constructing a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected by CFOs.
- User-Friendly: Intuitive interface suitable for users without extensive financial modeling skills.
Who Should Use This Product?
- Investors: Accurately assess AC Immune SA’s (ACIU) fair value prior to making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to AC Immune SA (ACIU).
- Consultants: Efficiently modify the template for valuation reports tailored to AC Immune SA (ACIU) clients.
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms like AC Immune SA (ACIU).
- Educators: Implement it as a teaching resource to illustrate valuation techniques relevant to AC Immune SA (ACIU).
What the Template Contains
- Pre-Filled DCF Model: AC Immune SA’s (ACIU) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate AC Immune SA’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.